Investment Summary

Boston Scientific Invests In M.I.Tech

On June 15, 2022, Boston Scientific invested in medical products company M.I.Tech from Synergy Innovation

Investment Highlights
  • This is Boston Scientific’s 44th transaction in the Medical Products sector.
  • This is Boston Scientific’s 1st transaction in South Korea.

Investment Summary

Date 2022-06-15
Target M.I.Tech
Sector Medical Products
Investor(s) Boston Scientific
Sellers(s) Synergy Innovation
Deal Type Stake Purchase

Target

M.I.Tech

Pyeongtaek-si, South Korea
M.I.Tech develops, manufactures, and provides its own unique medical devices in the field of digestive endoscopy to improve patients’ quality of life. It manufactures all products under a strict quality management system by maintaining the global standard, ISO 13485:2003. M.I.Tech was formed in 1991 and is based in Pyeongtaek-si, South Korea.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Boston Scientific

Marlborough, Massachusetts, United States

Category Company
Founded 1979
Sector Medical Products
Employees48,000
Revenue 16.7B USD (2024)
DESCRIPTION
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.

Boston Scientific is a medical technology company that offers products and technologies used to diagnose and treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.


DEAL STATS #
Overall 58 of 70
Sector: Medical Products M&A 44 of 53
Type: Stake Purchase M&A Deals 3 of 4
Country: South Korea M&A 1 of 1
Year: 2022 M&A 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-10-06 Baylis Medical

Montreal, Quebec, Canada

Baylis Medical is a developer and marketer of high-technology medical devices used in the fields of interventional cardiology and interventional radiology. The company’s core expertise lies in electrosurgical systems that are used to deliver various therapeutic treatments. Baylis Medical was founded in 1986 and is based in Montreal, Quebec.

Buy $1.8B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-15 Obsidio

Columbia, South Carolina, United States

Obsidio is a privately-held company that has developed the Gel Embolic Material technology used for embolization of blood vessels in the peripheral vasculature. Obsidio is based in Columbia, South Carolina.

Buy -

Seller(S) 1

SELLER

Synergy Innovation

Seongnam-si, South Korea

Category Company
Founded 1998
Sector Life Science
Employees72
Revenue 90.6B KRW (2024)
DESCRIPTION

Synergy Innovation is a bio management platform focused on nurturing the bio business as a new growth engine, and actively conducts R&D and internal and external investments in various fields such as generic and improved new drugs, new drug development, medical devices, and health functional foods to foster star companies in the bio industry. Synergy Innovation was formed in 1998 and is based in Seongnam-si, South Korea.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Stake Purchase M&A Deals 1 of 1
Country: South Korea M&A 1 of 1
Year: 2022 M&A 1 of 1